Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

View:
Post by ENEMENEMYNEMO on Aug 16, 2022 11:45am

Load up

Picked up a bunch today! This is fantastic news, suprised the sp isn't skyrocketing today, I think the market doesn't understand the importance of the info in this NR. It's nuanced but it's there... changing endpoint cus their review showed success. This is F'n huge. 

Remember they've looked at 200 hundred patients FINAL data...that's enough for statistical inference and Revive decides to submit for endpoint change. This isn't a whim or hope this is knowledge... without them clearly coming out with it yet until FDA reviewed. 

A pill to prescribe to mild Covid cases...$$$$$$$. I see every doctor writing scripts for this, hospital, nursing home prophylactics in outbreaks.

Comment by ENEMENEMYNEMO on Aug 16, 2022 12:16pm
Also interesting that this NR doesn't mention an application for EUA as their last few have....I'm hoping the reason being that they definitely are going to request EUA but wouldn't be able to comment on that aspect in this NR as they have seen the (positive ) data and mentioning that now before a FDA review wouldn't go over well with the FDA/SEC. They comment. "" ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities